105 related articles for article (PubMed ID: 38749437)
1. [New classifications of malignant lymphomas - What changes are relevant for practice?].
Hartmann S; Rudelius M
Dtsch Med Wochenschr; 2024 May; 149(11):613-620. PubMed ID: 38749437
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
[TBL] [Abstract][Full Text] [Related]
3. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
4. [Classification of indolent B-cell lymphomas : Novelties and open questions].
Anagnostopoulos I; Zamò A
Pathologie (Heidelb); 2023 May; 44(3):154-165. PubMed ID: 37093245
[TBL] [Abstract][Full Text] [Related]
5. [Classification of aggressive B-cell lymphomas : News and open questions].
Rosenwald A; Menter T; Dirnhofer S
Pathologie (Heidelb); 2023 May; 44(3):166-172. PubMed ID: 36918411
[TBL] [Abstract][Full Text] [Related]
6. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas.
Piccaluga PP; Khattab SS
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762472
[TBL] [Abstract][Full Text] [Related]
8. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
[TBL] [Abstract][Full Text] [Related]
9. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
[TBL] [Abstract][Full Text] [Related]
11. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.
Jaffe ES
Hematology Am Soc Hematol Educ Program; 2009; ():523-31. PubMed ID: 20008237
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
Lynch RC; Gratzinger D; Advani RH
Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
Falini B; Martino G; Lazzi S
Leukemia; 2023 Jan; 37(1):18-34. PubMed ID: 36460764
[TBL] [Abstract][Full Text] [Related]
16. Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.
El Dana F; Garces Narvaez SA; El-Mallawany NK; Agrusa JE; Dreyer ZE; Marcogliese AN; Elghetany MT; Punia JN; Ok CY; Patel KP; Lopez-Terrada DH; Fisher KE; Curry CV
Pediatr Dev Pathol; 2024 Mar; ():10935266241230600. PubMed ID: 38468555
[TBL] [Abstract][Full Text] [Related]
17. [Classification of malignant lymphomas. Current situation].
Koch K; Klapper W
Internist (Berl); 2016 Mar; 57(3):206-13. PubMed ID: 26800678
[TBL] [Abstract][Full Text] [Related]
18. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
Ohshima K; Suzumiya J; Kikuchi M
Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
[TBL] [Abstract][Full Text] [Related]
19. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique.
Wang J; Young L; Win W; Taylor CR
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):323-32. PubMed ID: 16280661
[TBL] [Abstract][Full Text] [Related]
20. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
Oishi N; Ahmed R; Feldman AL
Curr Hematol Malig Rep; 2023 Dec; 18(6):252-263. PubMed ID: 37870698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
